Pfizer,AstraZeneca COVID-19 vaccines less viable against Delta variation: Oxford-drove study Kumar Jeetendra | August 19, 2021 The COVID-19 vaccines by Pfizer and AstraZeneca are less effective against the Delta variant of coronavirus compared to the Alpha variant, according to a study led by researchers at the University of Oxford.The researchers, however, noted that with Delta, Pfizer-BioNTech vaccine and Oxford-AstraZeneca preventive, known as Covishield in India, still offer good protection against new …
Pfizer submits information for third dose endorsement in US Kumar Jeetendra | August 17, 2021 Pfizer and BioNTech on Monday submitted preliminary clinical data to US health authorities as part of their effort to seek authorization for a third dose of their Covid-19 vaccine for all Americans. Last week, the United States approved the booster shot of Pfizer-BioNTech and Moderna vaccines for people with weakened immune systems. Pfizer and BioNTech …
Wockhardt inks agreement to deliver, supply Sputnik vaccine to Dubai-based firm Kumar Jeetendra | August 13, 2021 Drug maker Wockhardt on Friday said it has inked a pact with Dubai-based Enso Healthcare and a subsidiary of Russian Direct Investment Fund (RDIF) for production and supply of COVID-19 vaccine Sputnik. The Mumbai-based firm has entered into an agreement with Enso and Human Vaccine LLC , a wholly owned unit of the management company of RDIF …
Cipla receives final approval for generic version of Durezol® Kumar Jeetendra | August 12, 2021 Mumbai, India; August 12, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Difluprednate Ophthalmic Emulsion 0.05% from the United States Food and Drug Administration (US FDA). Cipla’s Difluprednate Ophthalmic Emulsion 0.05% is AB-rated …
Provided more than 1 billion COVID-19 vaccine dose up until now: BioNTech Kumar Jeetendra | August 9, 2021 BioNTech and partner Pfizer have supplied more than one billion doses of their COVID-19 vaccine as per July 21, a bigger number than delivered by competitor AstraZeneca, the German biotech group said on Monday. The supply tally, up from more than 700 million doses announced by the biotech firm in June, compares with AstraZeneca saying …
Alembic Pharma gets last approval from USFDA for OCD treatment drug Kumar Jeetendra | August 5, 2021 New Delhi, Aug 5 (PTI) Drug firm Alembic Pharmaceuticals on Thursday said it has received final approval from the US health regulator for Clomipramine Hydrochloride capsules, used for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD). The company has received final approval from the US Food and Drug Administration (USFDA) for …
Consolidating AstraZeneca and mRNA COVID-19 vaccine is effective – Danish study Kumar Jeetendra | August 2, 2021 Combining AstraZeneca’s COVID-19 vaccine with a second dose from either Pfizer-BioNTech or Moderna’s jab provides “good protection”, Denmark’s State Serum Institute said on Monday. A growing number of countries are looking at switching to different COVID-19 vaccines for second doses, a measure particularly necessary in Denmark after health authorities discontinued inoculations with AstraZeneca’s vaccine in …
India says Johnson and Johnson pulls out proposal for quick COVID-19 vaccine approval Kumar Jeetendra | August 2, 2021 India’s drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details. The U.S.-based company had said in April it was seeking an approval to conduct a bridging clinical study of its Janssen COVID-19 vaccine candidate in India. Trials in the …
Pharmaceutical Roots – Almonds and Enantiomers Kumar Jeetendra | August 1, 2021 Pharmaceutical roots is a new series from LGC Mikromol, investigating and outlining the natural origins of pharmaceutical substances, and offering a deeper dive into their uses, risks, and mechanisms of action. Mandelic acid Mandelic acid is a small, aromatic compound with many different uses. Although these days it is usually prepared in the lab, mandelic …
Pharmaceutical Roots – The origins of opioids Kumar Jeetendra | August 1, 2021 Pharmaceutical roots is a new content series from LGC Mikromol, investigating and outlining the natural origins of pharmaceutical substances, and offering a deeper dive into their uses, risks, and Morphine is a type of opiate pain medication with a strong analgesic duration, lasting from three to seven hours. Named after Morpheus, the Greek god of …
Roche launches spinal muscular atrophy treatment drug in India evaluated at around Rs 6 lakh per bottle Kumar Jeetendra | July 30, 2021 Pharma major Roche on Thursday said it has launched prescription medicine Evrysdi in India, which is used for treatment of spinal muscular atrophy (SMA) in adults, children aged 2 months and older, at a maximum retail price of around Rs 6 lakh per bottle. Evrysdi was first approved by the United States Food and Drug …
Pfizer and AstraZeneca vaccine antibody levels might decrease following 2-3 months: Lancet study Kumar Jeetendra | July 27, 2021 Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to study published in The Lancet journal. The researchers from University College London (UCL) in the UK noted that if the antibody levels carry on dropping …
